Literature DB >> 16977807

Hyperventilatory capacity--a predictor of altitude sickness.

Azmat Hayat1, M Mazhar Hussain, Sohail Aziz, Abdul Hameed Siddiqui, Tassawar Hussain.   

Abstract

BACKGROUND: The aim of the study was to document link between hyperventilatory capacity and risk for developing acute mountain sickness (AMS).
METHODS: This study was carried out at Karakorum Mountain ranges (Northern areas of Pakistan) from March till July 2004. 54 healthy male subjects were enrolled in this study. Arterial oxygen saturation (SpO2) of the subjects was measured by the pulse oximeter at rest and after 1 minute of voluntary hyperventilation at an altitude of 2833 meters. Symptoms of acute mountain sickness (AMS) were recorded on a questionnaire by using the Lake Louise consensus scoring system 24 hours after ascent to high altitude.
RESULTS: Mean pre hyperventilation oxygen saturation (SpO2) was 94.07 + 0.26% whereas SpO2 after 01 minute of hyperventilation was 98.61 + 0.14% that was significantly increased (p<0.001). The mean increase in percent oxygen saturation of hemoglobin after one minute of hyperventilation (hyperventilatory capacity) for the study group was 4.61 +/- 0.24 % while the mean symptom score was 2.06 +/- 0.26. It was noted that 19 (35.2%) subjects did not develop AMS whereas 34(63.0%) subjects had mild AMS and only one subject developed moderate AMS. There was no case of severe AMS. The data reveals significant (P<0.01) association between hyperventilatory capacity and development of the symptoms of AMS (r = -0.664). It is evident that individuals with greater hyperventilatory capacity manifest less number of symptoms of mountain sickness.
CONCLUSION: It is concluded that post hyperventilation increase in oxygen saturation at lower altitude may help to predict the susceptibility of subjects to develop high altitude sickness.

Entities:  

Mesh:

Year:  2006        PMID: 16977807

Source DB:  PubMed          Journal:  J Ayub Med Coll Abbottabad        ISSN: 1025-9589


  4 in total

1.  Prediction of the susceptibility to AMS in simulated altitude.

Authors:  Martin Burtscher; Christoph Szubski; Martin Faulhaber
Journal:  Sleep Breath       Date:  2008-05       Impact factor: 2.816

2.  Do over 200 million healthy altitude residents really suffer from chronic Acid-base disorders?

Authors:  Gustavo Zubieta-Calleja; Gustavo Zubieta-Castillo; Luis Zubieta-Calleja; Gustavo Ardaya-Zubieta; Poul-Erik Paulev
Journal:  Indian J Clin Biochem       Date:  2010-11-16

3.  Three-Minute Step Test for Predicting Acute Mountain Sickness: A Post Hoc Analysis of Rhodiola Crenulata Extract for Prevention of Acute Mountain Sickness, a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Authors:  Hsiang Yun Lo; Lisa Li-Chuan Chen; Deng-Huang Su; Chung-Hsien Chen; Tai-Yi Hsu; Shih-Hao Wang; Yi-Ming Weng; Cheng-Wei Chan; Shih-Hao Wu; Hang-Cheng Chen; Te-Fa Chiu
Journal:  J Acute Med       Date:  2018-03-01

4.  The Magnitude of Diving Bradycardia During Apnea at Low-Altitude Reveals Tolerance to High Altitude Hypoxia.

Authors:  Pontus Holmström; Eric Mulder; Angelica Lodin Sundström; Prakash Limbu; Erika Schagatay
Journal:  Front Physiol       Date:  2019-08-22       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.